Abstract Empagliflozin (EMPA) is one of the sodium/glucose cotransporter 2 (SGLT2) inhibitors that has been recently approved for the treatment of diabetes mellitus type II
Rybelsus has additional safety considerations including potential worsening of diabetic retinopathy (particularly with rapid improvement in blood glucose control), risk of dehydration from gastrointestinal effects, increased risk of gallbladder disease, and caution in people with severe gastrointestinal disease or gastroparesis
here for gynecological issues, and with more on mast cells affecting pregnancy and postpartum: here, with the full study here.] Neurologic and Psychiatric : I remember reading a case study where a doctor reported a patient who said their panic attacks went away when I started my antihistamines
After her failed attempt at using Wegovy in the past, she had nothing but praises to sing about her experience Mounjaro
Chronic intermittent fasting improves the survival following large myocardial ischemia by activation of BDNF/VEGF/PI3K signaling pathway
Conversely, lactase and peptidase activities become more similar within the first weeks
